Mark Eisner - Mar 2, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Mar 2, 2023
Transactions value $
-$25,960
Form type
4
Date filed
3/6/2023, 03:59 PM
Previous filing
Feb 23, 2023
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$26K -1.19K -0.68% $21.87* 172K Mar 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.